ZEAL stock: buy or sell?
May 21st, 2019
Zealand Pharma A\u002FS, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark.
Should I buy ZEAL stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups are elegible for Zealand Pharma A/S stock right now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Zealand Pharma A/S stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we found 1 rating published for ZEAL stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-3-7||Needham & Company LLC||n/a||Buy|
ZEAL stock analysis
Zealand Pharma A/S boosted 3.90% today and topped a new all time high at $21.12.
Zealand Pharma A/S boosted 3.90% to $21.05 after topping to all time highs today. Since last Apr/23 when SMA100d and SMA200d crossed up, ZEAL price gained $2.75 per share (15.03%). Since last February when ZEAL stock price broke up the SMA200d line, it gained $6.75 (47.20%). ZEAL broke out again over $20.85 after a 5.08% correction started on May/14.
Zealand Pharma A/S topped new all time highs again this week, setting highs to $21.12. Shares closed at $21.05 and skyrocketed 6.05% during the week. Early April ZEAL collapsed a hair-raising -6.09% in just one week.
Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $14.72 resistance. Early April, SMA20w and SMA40w crossed up triggering a rise of 9.81%. Since price and SMA40w lines crossed up late January, ZEAL climbed $7.01 (49.93%).
ZEAL stock price history
ZEAL stock went public on August 9th, 2017 with a price of $18.121. Since then, ZEAL stock grew a 16.20%, with an average of 16.20% per year. If you had invested right after ZEAL's IPO a $1,000 in ZEAL stock in 2017, it would worth $162.00 today.
1: Adjusted price after possible price splits or reverse-splits.
ZEAL stock historical price chart
ZEAL stock reached all-time highs today with a price of $21.12.
ZEAL stock price target is $29.00Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we only found 1 price prediction for Zealand Pharma A/S stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-3-7||Needham & Company LLC||Reiterates||n/a||$29.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareZealand Pharma A/S let down experts on March when it published an Earnings per Share (EPS) of $-0.61 when the analysts' forecast was $-0.69.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Zealand Pharma A/S annual revenues plunged a scary -72.14% to $37.98 million dollars from $136.32 marked in 2017. When comparing 2018 vs 2017, instead, profit margin (that is, the net income divided by revenues) skyrocketed a 1,732.53% to 1,530.62%.
|2013||$6.57 M||-||$-183.68 M-2795.7%||-|
|2014||$154 M||2,240.53%||$-64.99 M-42.3%||-64.62%|
|2015||$188 M||22.05%||$-113.96 M-60.7%||75.35%|
|2016||$235 M||25.10%||$-153.91 M-65.6%||35.06%|
|2017||$136 M||-41.94%||$-275.26 M-201.9%||78.84%|
|2018||$38 M||-72.14%||$581 M1530.6%||-311.18%|
Quarterly financial resultsZealand Pharma A/S reported $13.12 M in sales for 2018-Q4, a inf% up compared to previous quarter. Reported quarter earnings marked $-122.97 M with a profit margin of -937.37%. Profit margin stayed steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Zealand Pharma A/S sales marked an amazing gain and boosted a 24.67%.
|2017-Q1||$78 M||-||$-26 M-33.9%||-|
|2017-Q2||$11 M||-86.09%||$-94 M-867.4%||255.79%|
|2017-Q3||$6 M||-41.44%||$-7 M-105.5%||-92.88%|
|2017-Q4||$11 M||66.39%||$-111 M-1051.6%||1,559.25%|
|2018-Q1||$11 M||2.91%||$-91 M-844.1%||-17.40%|
|2018-Q2||$15 M||39.77%||$-127 M-840.1%||39.12%|
|2018-Q4||$13 M||-13.33%||$-123 M-937.4%||-3.29%|
Zealand Pharma A/S ownershipWhen you are planning to invest in shares of a company, it's always worth to overview its ownership structure.
Zealand Pharma A/S shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.00% of all shares.
In case of Zealand Pharma A/S stock, 9.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ZEAL stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related companies:
|Market cap||$646.0 M|
|Total shares||30.7 M|
|Float shares||24.5 M|
|- Institutional holdings (%)||9.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Tuesday, May 21st, 2019|
|Day range||$20.68 - $21.12|
|Average true range||$0.51|
|50d mov avg||$18.49|
|100d mov avg||$16.08|
|200d mov avg||$15.24|
Zealand Pharma A/S performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Zealand Pharma A/S performance to :